Compare Agilent Technologies Inc (A) vs ProShares Ultra Silver ETF (AGQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs ProShares Ultra Silver ETF — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while ProShares Ultra Silver ETF trades at $79.45. The key difference: Agilent Technologies Inc pays a 0.69% dividend while ProShares Ultra Silver ETF pays none, and Agilent Technologies Inc is trading nearer its 52-week high, ProShares Ultra Silver ETF nearer its low. Which is the better fit depends on your goals.
| A | AGQ | |
|---|---|---|
Market Cap | $42.00B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $157.20 | $400.47 |
52-Week Low | $110.24 | $49.73 |
Enterprise Value | $43.55B | — |
Dividend Yield | 0.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
ProShares Ultra Silver (AGQ) is trading at $76.86, up 5.97% on strong silver price momentum. The technical picture shows bullish moving averages with RSI indicating potential overbought conditions near resistance at $78. Recent news highlights AGQ's 9.39% surge as silver rallied 4-5%, though structural decay concerns persist for this 2x leveraged ETF.
The outlook remains volatile with silver price movements driving performance. Investment opportunity exists for bullish silver investors seeking amplified exposure, but structural decay and beta slippage present significant risks. AGQ consistently underperforms unlevered silver ETFs over time, making it suitable only for short-term tactical positions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About ProShares Ultra Silver ETF
AGQ is a leveraged ETF that seeks daily investment results corresponding to two times (2x) the daily performance of silver bullion. It is designed for investors seeking magnified short-term exposure to silver prices.
Read more on AGQ →
